biosimilar
biosimilar
Revolutionary Cancer Drug Biosimilar Nears Trials!
**Excerpt:** 🌟 Scientists are developing a biosimilar for atezolizumab using CHO DG44 cells, showing promising effectiveness in cancer treatment! 🔬🧪📈
Boosting Biosimilar Adoption in Low-Income Countries: Revolutionary Process Optimization Techniques Unveiled!
🔍 A biosimilar manufacturer is using innovative techniques to cut costs and improve yields, boosting adoption in lower-income countries. Join them at the Bioprocessing Summit in Boston! 🌍💉🔬
Discover How Biosimilar Charge Variants Affect Drug Potency
Discover how charge variants in biosimilars can impact drug stability and potency, and the importance of demonstrating similarity. 🔬⚖️🧪
Overcoming the Biosimilar Bottleneck: The Solution to Medicine Shortages in Europe
🔍 Supply chain shortages in Europe worsened by pharmaceutical companies not licensing biosimilars. 🌍 A pan-European license could improve access. 💡 UK regulator encourages innovation. ⚙️ QTL technology can increase availability.
Alvotech’s Groundbreaking AVT03 Study: A Game-Changer in Osteoporosis Treatment
🔬 Alvotech SA reported positive results from a study of AVT03, a biosimilar candidate for osteoporosis treatment.
